fpl 55712 has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehta, JL; Nichols, WW | 1 |
| Cooper, DR; Kelliher, GJ; Kowey, PR | 1 |
2 other study(ies) available for fpl 55712 and Coronary Disease
| Article | Year |
|---|---|
Leukotriene-receptor antagonist FPL-55712 and t-PA-induced thrombolysis in canine coronary thrombosis.
Topics: Animals; Chromones; Coronary Disease; Coronary Thrombosis; Dogs; Drug Synergism; Leukotrienes; Neutrophils; Recurrence; SRS-A; Superoxides; Thrombolytic Therapy; Tissue Plasminogen Activator | 1990 |
Modulation of arachidonic acid metabolites and vulnerability to ventricular fibrillation during myocardial ischemia in the cat.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Cardiac Pacing, Artificial; Cats; Chromones; Coronary Disease; Female; Male; Naphthoquinones; ortho-Aminobenzoates; Pyrazoles; SRS-A; Sulfinpyrazone; Ventricular Fibrillation | 1988 |